LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma
Ballerup, DENMARK, December 23, 2019 – LEO Pharma announced the sale of 10 products to Karo Pharma AB for 90 MEUR. The divested portfolio is non-core to LEO Pharma's business, and was part of the portfolio acquired from Bayer in July 2019.Read the full story
Error while rendering view [NewsList]. The rendering is lacking some configuration. Please, read description below and try to fix the problem.
- The News List module is missing it's DataSource or no version exists for current language.